Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829384 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults
A Phase 1 study, sponsored by ModernaTX.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT03829384 is a Phase 1 study that has completed, run by ModernaTX. The registered enrollment target is 39 participants.
The verdict
NCT03829384, a Phase 1 study, has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
This is a Phase 1, FIH, single-center, randomized, placebo controlled, dose escalation study to evaluate the safety, tolerability, PK, and PD of mRNA-1944 in healthy adult subjects. Cohorts of mRNA-1944 are planned to be investigated in a sequential dose escalation manner.
Interventions
- OTHER Placebo
- BIOLOGICAL mRNA-1944
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2021-06-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03829384
The ClinicalTrials.gov registry entry for NCT03829384 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ModernaTX, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03829384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03829384 about?
NCT03829384 is a clinical study titled "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults". This is a Phase 1, FIH, single-center, randomized, placebo controlled, dose escalation study to evaluate the safety, tolerability, PK, and PD of mRNA-1944 in healthy adult subjects. Cohorts of mRNA-1944 are planned to be investigated in a sequential dose escalation manner.
What is the current status of trial NCT03829384?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2019-01-22. Estimated completion is 2021-06-07.
What interventions are being tested in trial NCT03829384?
The interventions under investigation include: Placebo (OTHER), mRNA-1944 (BIOLOGICAL).
Who is sponsoring clinical trial NCT03829384?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.